The Needs of Rare Disease Patients Cannot Be Forgotten in this Week’s Congressional Hearing on Lab Developed Diagnostic Tests (LDTs)
By Karin Hoelzer, Director of Policy and Regulatory Affairs at the National Organization for Rare Disorders (NORD) How should lab developed diagnostic tests (LDTs) be regulated? As the House Energy …
Read more